Tony Butler
Stock Analyst at Rodman & Renshaw
(0.56)
# 4,178
Out of 5,140 analysts
88
Total ratings
27.38%
Success rate
-22.46%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tony Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATRA Atara Biotherapeutics | Initiates: Buy | $25 | $4.60 | +443.48% | 2 | Dec 20, 2024 | |
| HURA TuHURA Biosciences | Initiates: Buy | $11 | $0.69 | +1,501.40% | 1 | Dec 19, 2024 | |
| BMEA Biomea Fusion | Upgrades: Buy | $18 | $1.41 | +1,176.60% | 4 | Sep 26, 2024 | |
| IPSC Century Therapeutics | Reiterates: Buy | $16 | $2.04 | +684.31% | 5 | Aug 10, 2023 | |
| FATE Fate Therapeutics | Reiterates: Buy | $10 | $1.18 | +747.46% | 4 | Aug 9, 2023 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $75 | $54.73 | +37.04% | 8 | Aug 8, 2023 | |
| GTBP GT Biopharma | Reiterates: Hold | $60 | $0.71 | +8,350.70% | 5 | Aug 7, 2023 | |
| CGEN Compugen | Reiterates: Buy | $13 | $2.11 | +516.11% | 6 | Aug 7, 2023 | |
| BCYC Bicycle Therapeutics | Reiterates: Buy | $50 | $6.90 | +624.64% | 5 | Aug 3, 2023 | |
| ALLO Allogene Therapeutics | Reiterates: Buy | $15 | $1.60 | +837.50% | 8 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $0.30 | +8,233.33% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $1.66 | +803.61% | 1 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $5.26 | +90.11% | 3 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $5.57 | +205.21% | 2 | Jul 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.3 → $166 | $3.40 | +4,782.35% | 4 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $7.26 | +726.45% | 4 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $2.33 | +10,200.43% | 4 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $0.29 | +1,958.32% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $360 | $1.33 | +26,967.67% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $5 → $2 | $3.14 | -36.31% | 6 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $1.32 | +1,036.36% | 1 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $10 | $2.19 | +356.62% | 2 | Feb 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $5.90 | +154.24% | 1 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $14.03 | +684.03% | 3 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $960 | $13.00 | +7,284.62% | 1 | Mar 2, 2020 |
Atara Biotherapeutics
Dec 20, 2024
Initiates: Buy
Price Target: $25
Current: $4.60
Upside: +443.48%
TuHURA Biosciences
Dec 19, 2024
Initiates: Buy
Price Target: $11
Current: $0.69
Upside: +1,501.40%
Biomea Fusion
Sep 26, 2024
Upgrades: Buy
Price Target: $18
Current: $1.41
Upside: +1,176.60%
Century Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $16
Current: $2.04
Upside: +684.31%
Fate Therapeutics
Aug 9, 2023
Reiterates: Buy
Price Target: $10
Current: $1.18
Upside: +747.46%
CRISPR Therapeutics AG
Aug 8, 2023
Reiterates: Buy
Price Target: $75
Current: $54.73
Upside: +37.04%
GT Biopharma
Aug 7, 2023
Reiterates: Hold
Price Target: $60
Current: $0.71
Upside: +8,350.70%
Compugen
Aug 7, 2023
Reiterates: Buy
Price Target: $13
Current: $2.11
Upside: +516.11%
Bicycle Therapeutics
Aug 3, 2023
Reiterates: Buy
Price Target: $50
Current: $6.90
Upside: +624.64%
Allogene Therapeutics
Aug 3, 2023
Reiterates: Buy
Price Target: $15
Current: $1.60
Upside: +837.50%
Aug 2, 2023
Reiterates: Buy
Price Target: $25
Current: $0.30
Upside: +8,233.33%
Jul 31, 2023
Initiates: Buy
Price Target: $15
Current: $1.66
Upside: +803.61%
Jul 12, 2023
Reiterates: Buy
Price Target: $10
Current: $5.26
Upside: +90.11%
Jul 7, 2023
Reiterates: Buy
Price Target: $17
Current: $5.57
Upside: +205.21%
Jul 3, 2023
Reiterates: Buy
Price Target: $8.3 → $166
Current: $3.40
Upside: +4,782.35%
Jun 7, 2023
Reiterates: Buy
Price Target: $60
Current: $7.26
Upside: +726.45%
Jun 5, 2023
Reiterates: Buy
Price Target: $240
Current: $2.33
Upside: +10,200.43%
Jun 1, 2023
Assumes: Buy
Price Target: $6
Current: $0.29
Upside: +1,958.32%
Jun 1, 2023
Assumes: Buy
Price Target: $360
Current: $1.33
Upside: +26,967.67%
May 30, 2023
Maintains: Hold
Price Target: $5 → $2
Current: $3.14
Upside: -36.31%
Jan 5, 2023
Initiates: Buy
Price Target: $15
Current: $1.32
Upside: +1,036.36%
Feb 17, 2022
Downgrades: Neutral
Price Target: $30 → $10
Current: $2.19
Upside: +356.62%
Nov 19, 2021
Initiates: Buy
Price Target: $15
Current: $5.90
Upside: +154.24%
Jun 28, 2021
Maintains: Buy
Price Target: $80 → $110
Current: $14.03
Upside: +684.03%
Mar 2, 2020
Initiates: Buy
Price Target: $960
Current: $13.00
Upside: +7,284.62%